Covid 19 Research using Clinical Trials (Home Page)
HP:0100743: Neoplasm of the rectumHPO
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated HPO Terms (0)
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
Clinical Trials
1 DElayed COloRectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)
To understand and analyse the global impact of COVID-19 on outpatient services, inpatient care, elective surgery, and perioperative colorectal cancer care, a DElayed COloRectal cancer surgery (DECOR-19) survey was conducted in collaboration with numerous international colorectal societies with the objective of obtaining several learning points from the impact of the COVID-19 outbreak on our colorectal cancer patients which will assist us in the ongoing management of our colorectal cancer patients and to provide us safe oncological pathways for future outbreaks.
NCT04488549 Colo-rectal Cancer Colon Cancer Rectal Cancer Oncology Surgery Other: Survey MeSH:Rectal Neoplasms
HPO:Neoplasm of the rectum
Primary Outcomes
Description: Respondents' and hospitals' demographics include: gender, country of origin, type of hospital (i.e. academic or not), type of unit (general surgery vs. colorectal), no. hospital beds, no. yearly surgeries for colon and rectal cancer, hospital preparedness to the emergency (i.e. fully or partially dedicated or not involved in COVID-19 care), readily availability of external facilities for colorectal cancer surgery, cancer care coordinator, personal protective equipment, status of elective surgery, no. elective colorectal cancer patients needing urgent surgery, any change in the original management plan, no. colorectal cancer patients refusing surgery or being COVID-19 + on surgery or becoming COVID-19 + post-operatively, no. staff members quarantined or relocated in COVID-19 units, MDT meeting suspension, any delay in endoscopy, radiology, oncology, surgery, histopathology.
Measure: Predictive power of respondents' and hospitals' demographics on delaying colorectal cancer care across 6 geographical regions Time: 20 days
HPO Nodes
HP:0100743: Neoplasm of the rectum
Genes 46
POLD1 AKT1 RNF43 PIK3CA SEMA4A SDHB KIT KRAS SDHA SDHC KIT MUTYH POLE KLLN BMPR1A POLE POLD1 KEAP1 GREM1 DICER1 SDHC MLH3 MSH2 STK11 PDGFRA PMS2 MSH3 TGFBR2 BMPR1A SMAD4 EPCAM SDHB ENG MSH6 PMS1 SEC23B PIK3CA NTHL1 RPS20 FAN1 USF3 PTEN BMPR1A SDHD MLH1 AXIN2 SNP 0
Primary Outcomes
Description: Respondents' and hospitals' demographics include: gender, country of origin, type of hospital (i.e. academic or not), type of unit (general surgery vs. colorectal), no. hospital beds, no. yearly surgeries for colon and rectal cancer, hospital preparedness to the emergency (i.e. fully or partially dedicated or not involved in COVID-19 care), readily availability of external facilities for colorectal cancer surgery, cancer care coordinator, personal protective equipment, status of elective surgery, no. elective colorectal cancer patients needing urgent surgery, any change in the original management plan, no. colorectal cancer patients refusing surgery or being COVID-19 + on surgery or becoming COVID-19 + post-operatively, no. staff members quarantined or relocated in COVID-19 units, MDT meeting suspension, any delay in endoscopy, radiology, oncology, surgery, histopathology.
Measure: Predictive power of respondents' and hospitals' demographics on delaying colorectal cancer care across 6 geographical regions Time: 20 days